GB202212626D0 - Cancer vaccine - Google Patents

Cancer vaccine

Info

Publication number
GB202212626D0
GB202212626D0 GBGB2212626.2A GB202212626A GB202212626D0 GB 202212626 D0 GB202212626 D0 GB 202212626D0 GB 202212626 A GB202212626 A GB 202212626A GB 202212626 D0 GB202212626 D0 GB 202212626D0
Authority
GB
United Kingdom
Prior art keywords
cancer vaccine
vaccine
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2212626.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terasom S R O
Original Assignee
Terasom S R O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terasom S R O filed Critical Terasom S R O
Priority to GBGB2212626.2A priority Critical patent/GB202212626D0/en
Publication of GB202212626D0 publication Critical patent/GB202212626D0/en
Priority to PCT/EP2023/073684 priority patent/WO2024047048A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4612—B-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/463—Cellular immunotherapy characterised by recombinant expression
    • A61K39/4634—Antigenic peptides; polypeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB2212626.2A 2022-08-31 2022-08-31 Cancer vaccine Ceased GB202212626D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2212626.2A GB202212626D0 (en) 2022-08-31 2022-08-31 Cancer vaccine
PCT/EP2023/073684 WO2024047048A1 (en) 2022-08-31 2023-08-29 Cancer vaccine comprising exosomes obtained or derived from activated and mature human b-lymphocytes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2212626.2A GB202212626D0 (en) 2022-08-31 2022-08-31 Cancer vaccine

Publications (1)

Publication Number Publication Date
GB202212626D0 true GB202212626D0 (en) 2022-10-12

Family

ID=83931840

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2212626.2A Ceased GB202212626D0 (en) 2022-08-31 2022-08-31 Cancer vaccine

Country Status (2)

Country Link
GB (1) GB202212626D0 (en)
WO (1) WO2024047048A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235877A (en) 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
KR20120081972A (en) * 2009-07-02 2012-07-20 아이티에이치 임뮨 세라피 홀딩스 에이비 Exosome based treatment of cancer

Also Published As

Publication number Publication date
WO2024047048A1 (en) 2024-03-07

Similar Documents

Publication Publication Date Title
GB202002166D0 (en) Vaccine
IL292272A (en) Cancer vaccine
EP4159234A4 (en) Sars-cov-2 vaccine
EP3919072A4 (en) Cancer vaccine preparation
GB201905780D0 (en) Cancer therapy
GB202108237D0 (en) Cancer methods
GB202212626D0 (en) Cancer vaccine
GB202016954D0 (en) Vaccine
GB202405562D0 (en) Cancer vaccine
EP4171619A4 (en) Breast cancer vaccine
GB202318238D0 (en) Vaccine
GB202301244D0 (en) Vaccine
GB202218142D0 (en) Vaccine
GB202218115D0 (en) Vaccine
GB202218002D0 (en) Vaccine
GB202215414D0 (en) Vaccine
GB202207281D0 (en) Vaccine
GB202200963D0 (en) Vaccine
GB202000739D0 (en) Cancer
GB202108828D0 (en) Novel cancer therapy
AU2019903260A0 (en) Cancer vaccine
IL304436A (en) Cancer therapy
GB202001963D0 (en) Cancer therapy
GB202000984D0 (en) Cancer therapy
GB202119115D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)